Lets Talk Patient Blood Management

What if a woman can be iron deficient and still not be anemic?

In Part 2 of my conversation with Professor Vernon Louw, we continue unpacking a clinical blog that questioned whether raising the lower limit of normal ferritin from 15 to 30 is simply creating a new disease in otherwise healthy people.

Vernon brings a very different perspective.

We talk about what the evidence tells us about ferritin below 30, why waiting for anemia may mean waiting too long, the symptoms women can experience before anemia develops, and why heavy menstrual bleeding deserves much more attention.

We also explore some unexpected territory—from bleeding disorders and the developing baby to the possible impact of changing nutrient levels in our food.

At the heart of the conversation is a deceptively simple question:

Should iron deficiency without anemia be recognized and treated, or are we medicalizing normal physiology?

And Vernon leaves us with a powerful message:

“Women have suffered for so many generations for so many reasons. Let's not make iron deficiency an additional one.”

Attend Dr. Louw's Masterclass on Iron Deficiency: https://academy.emguidance.com/course/iron-masterclass

Visit our Website:

https://www.letstalkpbm.com/

For generations of Jehovah's Witnesses, blood transfusionwasn't really a medical decision. The answer was simply no.

Now, for many blood components, that decision has becomea personal choice. But having a choice raises a new question: How do you make an informed one?

In this episode, Sarah sits down with Ben Walker, a former Jehovah's Witness elder who once provided pastoral support to Witness patients facing life-and-death medical decisions. Together, they talk candidly about the recent change and the questions it raised for him about blood transfusion.

What are the real risks of transfusion today? When canblood be lifesaving? When might it be avoided? What alternatives are available through Patient Blood Management? And what should patients ask their medicalteam before saying yes or no?

This isn't a conversation about telling anyone what decision to make. It's about understanding your options so the decision can truly be yours.

Resources Discussed:

https://www.shotuk.org/

Pattakoset al., Arch Intern Med 2012 – PubMed

EurekAlertpress release on Pattakos study

Marik& Corwin, Crit Care Med 2008 – PubMed

Reviewof JW cardiac surgery outcomes – PMC

Visit our website:

https://www.letstalkpbm.com/

Is iron deficiency without anemia a real diagnosis, or ismedicine turning healthy women into patients?

Prof. Vernon Louw, researcher, professor, and Executive Headof the Department of Medicine at the University of Stellenbosch, is an international authority on the global burden of iron deficiency and anemia. In Part 1 of this two-part conversation, he joins Sarah Walbolt, BSN RN, to takeapart a widely shared blog post arguing that raising the lower limit of normal ferritin from 15 to 30 in women creates a disease out of thin air.

Prof. Louw explains what ferritin actually measures, whyiron deficiency anemia is the last stage of iron deficiency rather than the first, and why the old reference range of 15 came from studies that never asked women about their periods. He walks through the evidence linking a ferritinunder 30 to fatigue, hair loss, pregnancy outcomes, fertility, and a 46% relative increase in Alzheimer's risk in a study of 70,000 adults. And he names the pattern plainly: when we tell women that heavy bleeding and exhaustion arenormal, that is medical gaslighting.

If you have ever been told your labs are normal while youstill felt awful, listen to this one.

Part 2 is coming soon.

Your Blood. Your Health.

This podcast is for education and is not medical advice.Talk to your own clinician about your labs and your care.

Visit our website: https://www.letstalkpbm.com/

Are blood transfusions always the best option? Modern medicine is changing the way we think about blood transfusions, anemia, and surgery, and every patient should know why.

In this episode of Let's Talk PBM, host Sarah is joined by Joshua Ozawa-Morriello, Nurse Practitioner, and Kelly Martin, RN, quality leader and Patient Blood Management (PBM) program expert, to explore the myths and realities surrounding blood transfusions and the growing movement toward Patient Blood Management (PBM).

Together, they discuss:

• Why blood transfusions aren't always the first or best treatment
• What Patient Blood Management (PBM) means for patients; how anemia can impact surgery and recovery
• Why optimizing your own blood before surgery matters
• Questions every patient should ask before receiving a blood transfusion.
• The evolution of PBM into an officially recognized nursing specialty.
• How this change is improving patient safety and healthcare outcomes worldwide.

Whether you're preparing for surgery, living with anemia, caring for a loved one, or simply interested in the future of medicine, this conversation offers valuable insights into how healthcare is evolving to improve patient outcomes while preserving one of our most precious resources; our own blood.

💬 What questions do you have about blood transfusions or preparing for surgery? Share them in the comments—we'd love to hear from you!

👍 If you enjoyed this episode, please Like, Subscribe, and Share to help more people learn about Patient Blood Management and informed healthcare decisions.

Visit Us: https://www.letstalkpbm.com/

#PatientBloodManagement #BloodTransfusion #Surgery #Anemia #Healthcare #PatientSafety #BloodHealth #Nursing #Medicine #LetsTalkPBM

What actually happens in the first 60 minutes after a majorinjury occurs? Trauma surgeon Dr. Erin Suydam (Allegheny Health Network) takesus inside the trauma bay to break down the "golden hour" — thecritical window where survival is decided by seconds, not hours.

In this episode, Dr. Suydam explains:
🩸What happens the moment a Level 1 trauma page comes in
🩸The ABCDE primary survey trauma teams use to save lives
🩸Why "massive hemorrhage protocol" replaced "massive transfusion protocol"
🩸Hemorrhagic shock vs. neurogenic shock — and why the difference matters
🩸What "damage control surgery" is and why some patients need multiple operations
🩸What bystanders can actually do to help before EMS arrives (Stop the Bleed)

Trauma is the #3 cause of death in the U.S. — this conversation is a rare, honest look at the split-second decisions that separate life from death, straight from someone who lives it.

⏱️ TIMESTAMPS
00:00 Meet Dr. Erin Suydam
01:38 Inside the trauma bay: how a Level 1 page works
02:50 What is the golden hour?
03:54 How the trauma team organizes in seconds
05:38 The ABCDE primary survey explained
07:48 Massive hemorrhage protocol vs. massive transfusion
09:24 Can giving blood too fast cause harm?
12:20 Making life-or-death calls with zero information
14:00 Hemorrhagic shock vs. neurogenic shock
19:20 From ER to OR: racing the clock
20:04 What is damage control surgery?
24:29 Trauma is the #3 cause of death — here's why
25:06 What bystanders can do to save a life

If you found this eye-opening, subscribe for more real conversations with the doctors, surgeons, and first responders working on the front lines of emergency medicine.

Visit our website: www.letstalkpbm.com

#TraumaSurgery #GoldenHour #EmergencyMedicine #TraumaSurgeon#StopTheBleed #MedicalPodcast #HemorrhagicShock #ICU #EmergencyRoom #MedTwitter#Surgery #FirstResponders #MassiveTransfusion #TraumaCenter

In this episode of Let’s Talk Patient Blood Management, we dig into one of the boldest platelet stewardship moves in recent years: cutting prophylactic platelet doses in halffor cancer patients without increasing bleeding.

Lead author Christine Cahill and Dr. Majed Refaai explain why platelets are overused, always in short supply, and far from a benign therapy. They walk us through how arbitrarythresholds like ‘hemoglobin 10’ and ‘platelets 50’ became ingrained, and what happened when their team at the University of Rochester implemented half‑dose plateletsin the real world, and why many ‘just in case’ transfusions may never have been needed in the first place.

We cover:

• Why platelets are prothrombotic and proinflammatory
• How 'just in case' transfusions can lead to refractoriness and no compatible units available
• Blood Inventory pressures of a level 1 trauma center, and triaging platelets to those who truly need them
• Real-world outcomes when platelet volumes are cut in half

If you have ever ordered one unit just to feel better about a lab value, then this conversation will challenge how you think about prophylactic transfusion, safety, dose, and indication.

Read Article Here: https://pubmed.ncbi.nlm.nih.gov/42087249/

Visit Let's Talk PBM Website:

https://letstalkpbm.com/

Music Created with SUNO

What if the future of heart and lung transplantation is using little to no donor blood at all?In this powerful episode of Let's Talk Patient Blood Management, Sarah Walbolt and Christine Cahill sit down with pioneering transplant surgeons Dr. Valluvan Jeevanandam and Dr. Pablo Sanchez from the University of Chicago Medicine to explore how their team is redefining what’s possible in modern surgery.These surgeons are performing some of the highest-risk operations in medicine — including heart transplants and double lung transplants — while dramatically reducing or eliminating the need for blood transfusion.In this episode:• How bloodless transplant surgery became possible• Why minimizing transfusion may improve patient outcomes• The culture, precision, and teamwork required behind the scenes• What most hospitals still misunderstand about transfusion-free care• Why patients travel from around the world seeking this expertise• The role of Patient Blood Management in the future of surgeryDr. Jeevanandam shares the deeply personal story that sparked his passion for reducing surgical bleeding, while Dr. Sanchez explains the meticulous surgical strategies that make these complex operations possible.This conversation goes far beyond transfusion medicine. It’s about innovation, surgical excellence, patient-centered care, and challenging long-held assumptions in healthcare.Whether you are a clinician, surgeon, perfusionist, nurse, healthcare leader, or simply fascinated by the future of medicine, this is an episode you won’t want to miss.Visit our website: https://letstalkpbm.com/

Dr. Michael Moront has spent over 30 years masteringbloodless cardiac surgery, saving lives where others see only impossibility. In this episode, he reveals the transformative power of patient blood management and how viscoelastic testing revolutionized his practice, reducing re-operationrates from 6.5% to 2.3% and significantly lowering six-month mortality.

Discover how thromboelastography and targeted bloodconservation strategies turn the impossible into routine. Dr. Moront shares detailed frameworks like "dry in, dry out" and how proactive preoperative optimization, innovative technologies, and team synergy make bloodless surgery safer, more effective, and increasingly standard. You'lllearn why meticulous technique, real-time data, and collaboration between surgeons, anesthesiologists, and perfusionists are key to avoiding transfusions, controlling bleeding, and improving patient outcomes across disciplines.

This episode also explores the broader impact of bloodless medicine, how it has driven innovations in minimally invasive technologies, pharmacologic innovations, and hospital protocols, paving the way for universal, patient-centered care. Dr.Moront emphasizes that neglecting these advancements risks missed opportunities and poorer patient results.

Gain insight into the future of personalized bloodmanagement research and how hospital leadership can champion these practices to elevate care standards regionally and nationally. Ideal for clinicians, hospital administrators, and health-conscious patients alike, this conversation highlights the future of surgery, where precision, innovation, and respect for patient choices create new frontiers in medicine.

 This is your front-row seat to the future of safer, smarter, and more compassionate surgical care.

Visit our Website to learn more about our work and partners.

www.letstalkpbm.com

Not all blood donations are the same, andnot every donor experience is straightforward.

In this episode, we lean on the expertise of Joel Addams,MD, MA, FCAP, Medical Director of Clinical Pathology, to walk through what reallyhappens before, during, and after you donate blood.

From the questions you’ll be asked to why you might be turned away, we unpack the critical differences between screening and testing, what ensures the safety of the blood supply, and where ethics come into play.

But this conversation goes further.

Through the lens of Patient Blood Management, wechallenge the assumption that donating blood is always a simple “yes”—and instead explore how donors and clinicians alike can make informed, thoughtful decisions.

Because this isn’t just about giving blood.
It’s about understanding it.

Have a story or concern about blood donation ethics? Shareit in the comments. We’re listening and may feature it in a future episode.

In this episode, MaryAnn and Dr. Caroline Alquist delve intothe complexities of HLA (Human Leukocyte Antigen) and its critical role in patient blood management. They discuss how HLA serves as a genetic fingerprint that influences transfusion outcomes, the importance of avoiding unnecessarytransfusions, and the ethical considerations surrounding blood donation.

Theconversation also highlights advancements in HLA testing technology and thesignificance of donor diversity in improving blood health, particularly for minority communities. Dr. Alquist emphasizes the need for patient advocacy and understanding of HLA testing to ensure better health outcomes.

Takeaways:

 HLA is crucial for understanding immune responses intransfusions.

Transfusion-related immunomodulation (TRIM) can affectpatient outcomes.

Avoiding unnecessary transfusions is a key goal in patientblood management.

HLA typing is essential for patients requiring specializedtransfusions.

Increasing donor diversity is vital for matching patientseffectively.

Virtual cross-matching technology enhances organ allocationefficiency.

HLA typing can predict patient responses to certainmedications.

Blood is a limited resource, and careful management isessential.

Let's Talk PBM Website:https://letstalkpbm.com/

Check out Dr. Alquist's podcast here:

https://youtu.be/QUzsbEG1k-w?si=MLFCYT8zuFVRneKW